Literature DB >> 15223251

Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis.

Mathula Thangarajh1, Andreia Gomes, Thomas Masterman, Jan Hillert, Peter Hjelmström.   

Abstract

The role of B cells and antibodies in the pathogenesis of multiple sclerosis (MS) is controversial. We investigated the expression of B-cell-activating factor of the tumor necrosis factor family (BAFF), a protein indispensable for B-cell survival, and of its three receptors in MS patients and controls. BAFF mRNA levels in monocytes, and BAFF-receptor mRNA in B and T cells, were higher in patients than in healthy controls; yet, BAFF protein levels in cerebrospinal fluid and plasma were similar in patients and headache controls. In addition, each MS disease course was associated with a unique expression pattern for all four molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223251     DOI: 10.1016/j.jneuroim.2004.03.017

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  23 in total

Review 1.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.

Authors:  Honghao Wang; Kai Wang; Xiaonan Zhong; Wei Qiu; Yongqiang Dai; Aimin Wu; Xueqiang Hu
Journal:  J Clin Immunol       Date:  2012-05-30       Impact factor: 8.317

3.  Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  Jérémie Sellam; Corinne Miceli-Richard; Jacques-Eric Gottenberg; Marc Ittah; Frédéric Lavie; Christine Lacabaratz; Nicolas Gestermann; Alexis Proust; Olivier Lambotte; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2006-12-21       Impact factor: 19.103

Review 4.  Targeting BAFF in autoimmunity.

Authors:  Anne Davidson
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

Review 5.  The function of BAFF on T helper cells in autoimmunity.

Authors:  Maogen Chen; Xiaohong Lin; Ya Liu; Qiang Li; Yiling Deng; Zhongmin Liu; David Brand; Zhiyong Guo; Xiaoshun He; Bernhard Ryffel; Song Guo Zheng
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-24       Impact factor: 7.638

6.  Atacicept: targeting B cells in multiple sclerosis.

Authors:  Hans-Peter Hartung; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

Review 7.  The potential role of B cell-targeted therapies in multiple sclerosis.

Authors:  Aaron Boster; Daniel P Ankeny; Michael K Racke
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

8.  Diagnostic value of fecal B cell activating factor in patients with abdominal discomfort.

Authors:  C Xie; R Quan; L Wang; C Chen; W Yan; Y Fu
Journal:  Clin Exp Immunol       Date:  2019-08-05       Impact factor: 4.330

Review 9.  [Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis].

Authors:  H-P Hartung
Journal:  Nervenarzt       Date:  2009-12       Impact factor: 1.214

Review 10.  What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?

Authors:  Katherine A Buzzard; Simon A Broadley; Helmut Butzkueven
Journal:  Int J Mol Sci       Date:  2012-10-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.